financetom
Business
financetom
/
Business
/
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
Jan 14, 2025 10:18 AM

01:09 PM EST, 01/14/2025 (MT Newswires) -- Cymat Technologies ( CYMHF ) on Tuesday entered into a joint development agreement with an established Japanese trading and manufacturing company specializing in automotive, chemicals, plastics, electronics and life science products, pushing the company's shares up 39%.

The company said primary purpose of the agreement is to jointly develop innovative automotive solutions for EV battery function and protection based on customer demand. Cymat ( CYMHF ) has already been collaborating with the Japanese company for almost a year to advance its first initiative in response to OEM interest.

The initial component that the partnership is developing is a lightweight, multi-functional automotive EV battery encasement targeted to a particular Japanese original equipment manufacturer (OEM).

The partnership aims to initially enhance the component in terms of its battery functionality and level of impact resistance needed by the targeted Japanese OEM. The company said the new design is already undergoing physical testing to validate design performance metrics.

The partnership is in the process of filing patents to protect the innovative elements of this design and are in discussions with a major Japanese Tier 1 automotive manufacturer to assemble this component.

"We are very excited to be working with a world-class partner on this new EV battery component. We believe that these modifications to our original OEM component will hold broader appeal throughout the automotive industry," said Cymat ( CYMHF ) Chief Executive Michael Liik. "This sector is highly motivated to utilize lighter, cost-effective, energy-absorbing materials in its quest to effectively compete in the new EV landscape."

Shares of the company were last seen up $0.045 to $0.16 on the TSX Venture Exchange.

Price: 0.16, Change: +0.05, Percent Change: +39.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising,
Honeywell's Potential Split to Become Two Companies Would Be 'Welcome' But 'Not Surprising," UBS Says
Jan 14, 2025
01:06 PM EST, 01/14/2025 (MT Newswires) -- Honeywell International ( HON ) could soon disclose plans to become two companies, with the move that may be announced as soon as early February described as a welcome but not surprising development for the industrial conglomerate, UBS analysts said in a Monday research note. Citing people familiar with the matter, Bloomberg reported...
Eli Lilly Tempers Fourth-Quarter, Full-Year Revenue Expectations; Shares Decline
Eli Lilly Tempers Fourth-Quarter, Full-Year Revenue Expectations; Shares Decline
Jan 14, 2025
01:07 PM EST, 01/14/2025 (MT Newswires) -- Shares of Eli Lilly ( LLY ) tumbled intraday Tuesday after the drugmaker lowered fourth-quarter and full-year revenue expectations amid slower-than-expected growth in its US incretin division. The company now expects fourth-quarter revenue of about $13.5 billion, down $400 million from its previous outlook's low end. Analysts polled by FactSet expected $13.93 billion....
Update: Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Update: Major US Pharmacy Benefit Managers Inflated Drug Prices for Over $7.3 Billion Gain, FTC Says
Jan 14, 2025
01:05 PM EST, 01/14/2025 (MT Newswires) -- (Updates with CVS Health's ( CVS ) response in the fifth and sixth paragraphs.) UnitedHealth Group's ( UNH ) OptumRx, CVS Health's ( CVS ) Caremark Rx and Cigna's ( CI ) Express Scripts marked up a number of specialty generic drugs at their affiliated pharmacies by hundreds or thousands of percent, the...
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
Cymat Technologies Up 39% After Partnering With Major Japanese Trading And Manufacturing Co. In Joint Development Agreement
Jan 14, 2025
01:09 PM EST, 01/14/2025 (MT Newswires) -- Cymat Technologies ( CYMHF ) on Tuesday entered into a joint development agreement with an established Japanese trading and manufacturing company specializing in automotive, chemicals, plastics, electronics and life science products, pushing the company's shares up 39%. The company said primary purpose of the agreement is to jointly develop innovative automotive solutions for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved